# OnCo record mt-302 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mt-302/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mt-302" ;
  schema:name "MT-302"@en ;
  schema:description "MT-302 programs myeloid immune cells inside the body to recognise TROP-2-bearing cancers. It is an experimental treatment in an early clinical trial."@en ;
  schema:url <https://onco.cc/drugs/mt-302/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05969041>, <https://doi.org/10.1200/JCO.2025.43.16_suppl.2591> ;
  onco:status "phase-1" ;
  onco:modality "In vivo myeloid cell therapy (mRNA lipid nanoparticles)" ;
  onco:targets <https://onco.cc/targets/trop2/> ;
  onco:trials <https://onco.cc/trials/nct05969041/> .